A study to compare Vyoshadi Guggulu and Amritadi Guggulu in improving blood sugar levels in people with Prediabetes.

A comparative clinical trial to evaluate the effect of Vyoshadi Guggulu and Amritadi Guggulu in the management of Prediabetes - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/104786

Enrollment

Registered

2026-02-25

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E00-E89- Endocrine, nutritional and metabolic diseases

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Subjects fulfilling the following diagonostic criteria that is FBS is 100 to 125 mg/dl or HbA1c between 5.7 and 6.4 percent. sample comes under moderate risk and high risk groups according to IDRS Scale. Sample who fulfill the criteria and willing to sign written informed consent for participation

Exclusion criteria

Exclusion criteria: Known case of diabetes mellitus that is greater than or equal to 126 mg/dl or HbA1C greater than or equal to 6.5 percent. Current use of Antidiabetic medications and Insulin Known case of Renal failure,Cardio vascular disease or Cancer. Pregnant ladies and lactating mothers. Severe psychiatric illness or cognitive disorders interfering with compliance. People with alcohol dependency and drug dependency

Design outcomes

Primary

Measure	Time frame
To manage the HbA1c levels in Prediabetes.Timepoint: Assessment will be done on Day 91	—

Secondary

Measure	Time frame
To compare the effect of both the drugs in the management of HbA1c levels in prediabetesTimepoint: 91 days	—

Countries

India

Contacts

Public ContactAnjaly Peius

Sri Jayendra Saraswathi Ayurveda College and Hospital,Chennai,Tamilnadu.

pkm_ayur@yahoo.com9444123608

Outcome results